questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Protéines de transport membranaire
Protéines transporteurs de solutés
Symporteurs des ions sodium-potassium-chlorure
Symporteurs des ions sodium-potassium-chlorure : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Symporteurs des ions sodium-potassium-chlorure : Questions médicales les plus fréquentes",
"headline": "Symporteurs des ions sodium-potassium-chlorure : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Symporteurs des ions sodium-potassium-chlorure : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-13",
"dateModified": "2025-03-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Symporteurs des ions sodium-potassium-chlorure"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines transporteurs de solutés",
"url": "https://questionsmedicales.fr/mesh/D000070590",
"about": {
"@type": "MedicalCondition",
"name": "Protéines transporteurs de solutés",
"code": {
"@type": "MedicalCode",
"code": "D000070590",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.937"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Membre-1 de la famille-12 des transporteurs de solutés",
"alternateName": "Solute Carrier Family 12, Member 1",
"url": "https://questionsmedicales.fr/mesh/D064466",
"about": {
"@type": "MedicalCondition",
"name": "Membre-1 de la famille-12 des transporteurs de solutés",
"code": {
"@type": "MedicalCode",
"code": "D064466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.937.875.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Membre-2 de la famille-12 des transporteurs de solutés",
"alternateName": "Solute Carrier Family 12, Member 2",
"url": "https://questionsmedicales.fr/mesh/D064506",
"about": {
"@type": "MedicalCondition",
"name": "Membre-2 de la famille-12 des transporteurs de solutés",
"code": {
"@type": "MedicalCode",
"code": "D064506",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.937.875.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Membre-3 de la famille-12 des transporteurs de solutés",
"alternateName": "Solute Carrier Family 12, Member 3",
"url": "https://questionsmedicales.fr/mesh/D064486",
"about": {
"@type": "MedicalCondition",
"name": "Membre-3 de la famille-12 des transporteurs de solutés",
"code": {
"@type": "MedicalCode",
"code": "D064486",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.937.875.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Membre-4 de la famille-12 des transporteurs de solutés",
"alternateName": "Solute Carrier Family 12, Member 4",
"url": "https://questionsmedicales.fr/mesh/D064507",
"about": {
"@type": "MedicalCondition",
"name": "Membre-4 de la famille-12 des transporteurs de solutés",
"code": {
"@type": "MedicalCode",
"code": "D064507",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.937.875.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Symporteurs des ions sodium-potassium-chlorure",
"alternateName": "Sodium-Potassium-Chloride Symporters",
"code": {
"@type": "MedicalCode",
"code": "D028021",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert A Fenton",
"url": "https://questionsmedicales.fr/author/Robert%20A%20Fenton",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedicine, Aarhus University, Aarhus, Denmark."
}
},
{
"@type": "Person",
"name": "Juan Pablo Nicola",
"url": "https://questionsmedicales.fr/author/Juan%20Pablo%20Nicola",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Biochemistry, National University of Córdoba, Córdoba, Argentina."
}
},
{
"@type": "Person",
"name": "Rebekka Spellerberg",
"url": "https://questionsmedicales.fr/author/Rebekka%20Spellerberg",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine IV, University Hospital, LMU Munich, 81377 Munich, Germany."
}
},
{
"@type": "Person",
"name": "Carolin Kitzberger",
"url": "https://questionsmedicales.fr/author/Carolin%20Kitzberger",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine IV, University Hospital, LMU Munich, 81377 Munich, Germany."
}
},
{
"@type": "Person",
"name": "Peter J Nelson",
"url": "https://questionsmedicales.fr/author/Peter%20J%20Nelson",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine IV, University Hospital, LMU Munich, 81377 Munich, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[The OMAGE comprehension interview: a method for building patient-centered care plans].",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/38880599",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.soin.2024.04.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Team Factors in Ethical Decision Making: A Content Analysis of Interviews with Scientists and Engineers.",
"datePublished": "2024-08-29",
"url": "https://questionsmedicales.fr/article/39207593",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11948-024-00499-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Facilitators of and barriers to County Behavioral Health System Transformation and Innovation: an interview study.",
"datePublished": "2024-05-09",
"url": "https://questionsmedicales.fr/article/38720309",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-024-11041-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Factors Influencing the Implementation of Digital Advance Care Planning: Qualitative Interview Study.",
"datePublished": "2024-08-16",
"url": "https://questionsmedicales.fr/article/39151167",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/50217"
}
},
{
"@type": "ScholarlyArticle",
"name": "Stories of Backlash in Interviews With Survivors of Intimate Partner Violence Against Women in Sweden.",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35816435",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10778012221088312"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de transport membranaire",
"item": "https://questionsmedicales.fr/mesh/D026901"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines transporteurs de solutés",
"item": "https://questionsmedicales.fr/mesh/D000070590"
},
{
"@type": "ListItem",
"position": 7,
"name": "Symporteurs des ions sodium-potassium-chlorure",
"item": "https://questionsmedicales.fr/mesh/D028021"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Symporteurs des ions sodium-potassium-chlorure - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Symporteurs des ions sodium-potassium-chlorure",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Symporteurs des ions sodium-potassium-chlorure",
"description": "Comment diagnostiquer une dysfonction des symporteurs ?\nQuels examens sont utilisés pour évaluer les symporteurs ?\nQuels symptômes indiquent une anomalie des symporteurs ?\nPeut-on détecter des mutations génétiques liées aux symporteurs ?\nQuel rôle joue l'imagerie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Interviews+as+Topic&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Symporteurs des ions sodium-potassium-chlorure",
"description": "Quels symptômes sont liés à une défaillance des symporteurs ?\nComment se manifestent les déséquilibres électrolytiques ?\nLes symptômes varient-ils selon l'âge ?\nQuels signes cliniques sont observés ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Interviews+as+Topic&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Symporteurs des ions sodium-potassium-chlorure",
"description": "Comment prévenir les déséquilibres électrolytiques ?\nLes exercices physiques influencent-ils les symporteurs ?\nQuels aliments sont bénéfiques pour les symporteurs ?\nFaut-il surveiller les médicaments diurétiques ?\nLes contrôles médicaux réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Interviews+as+Topic&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Symporteurs des ions sodium-potassium-chlorure",
"description": "Quels traitements sont disponibles pour les déséquilibres ?\nComment les diurétiques affectent-ils les symporteurs ?\nLes traitements sont-ils personnalisés ?\nQuel rôle joue l'hydratation dans le traitement ?\nLes thérapies géniques sont-elles une option ?",
"url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Interviews+as+Topic&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Symporteurs des ions sodium-potassium-chlorure",
"description": "Quelles complications peuvent survenir ?\nLes complications sont-elles graves ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles évitables ?\nQuel suivi est nécessaire après des complications ?",
"url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Interviews+as+Topic&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Symporteurs des ions sodium-potassium-chlorure",
"description": "Quels sont les facteurs de risque des déséquilibres ?\nL'âge influence-t-il le risque de déséquilibres ?\nLe stress a-t-il un impact sur les symporteurs ?\nLes maladies chroniques augmentent-elles le risque ?\nLes habitudes de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Interviews+as+Topic&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des symporteurs ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires peuvent évaluer les niveaux d'électrolytes et la fonction rénale."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les symporteurs ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électrophorèse et les tests de fonction rénale aident à évaluer l'activité des symporteurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des symporteurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres électrolytiques peuvent provoquer fatigue, crampes et troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des mutations génétiques liées aux symporteurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant les symporteurs ioniques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à évaluer les organes affectés par des déséquilibres ioniques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une défaillance des symporteurs ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent déshydratation, hypertension, et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les déséquilibres électrolytiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent se manifester par des crampes musculaires, des palpitations et de la confusion."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées peuvent présenter des symptômes différents."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut observer une faiblesse musculaire, des nausées et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avec un traitement approprié, de nombreux symptômes peuvent être réversibles."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres électrolytiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et une hydratation adéquate aident à prévenir les déséquilibres."
}
},
{
"@type": "Question",
"name": "Les exercices physiques influencent-ils les symporteurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier aide à maintenir un bon équilibre électrolytique."
}
},
{
"@type": "Question",
"name": "Quels aliments sont bénéfiques pour les symporteurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les aliments riches en potassium, sodium et chlorure, comme les bananes, sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller les médicaments diurétiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est important de surveiller l'utilisation des diurétiques pour éviter les déséquilibres."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers aident à détecter précocement les déséquilibres électrolytiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les déséquilibres ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des suppléments d'électrolytes et des médicaments diurétiques."
}
},
{
"@type": "Question",
"name": "Comment les diurétiques affectent-ils les symporteurs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les diurétiques inhibent les symporteurs, augmentant l'excrétion d'eau et d'électrolytes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels du patient."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hydratation dans le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hydratation est essentielle pour maintenir l'équilibre électrolytique."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles une option ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur les thérapies géniques pour corriger les mutations des symporteurs."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des arythmies cardiaques, des convulsions et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent être potentiellement mortelles si non traitées."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des limitations physiques et des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles évitables ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par une gestion proactive des déséquilibres."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire après des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est essentiel pour surveiller les effets à long terme."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des déséquilibres ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent une alimentation déséquilibrée, des maladies rénales et des médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de déséquilibres ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des déséquilibres électrolytiques."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les symporteurs ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter l'équilibre électrolytique et la fonction des symporteurs."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète et l'hypertension augmentent le risque de déséquilibres."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et l'alcoolisme peuvent augmenter le risque."
}
}
]
}
]
}
OMAGE comprehension interviews (CIs) use a card game as a vehicle for active listening. CIs performed by training professionals revealed new information for 92% of patients. CIs seem to be an effectiv...
The ethical decision making of researchers has historically been studied from an individualistic perspective. However, researchers rarely work alone, and they typically experience ethical dilemmas in ...
Inadequate and inequitable access to quality behavioral health services and high costs within the mental health systems are long-standing problems. System-level (e.g., fee-for-service payment model, l...
We collected interview data from County or health care agency leaders, contracted partners, and community stakeholders. Themes were informed by the Consolidated Framework for Implementation Research....
Five themes were identified related to behavioral health system transformation, including 1) aligning goals and values, 2) addressing fit, 3) fostering engagement and partnership, 4) being aware of im...
The study highlights the multifaceted factors that help facilitate or hinder behavioral health system transformation, such as the need for addressing systematic and process behaviors, leveraging the k...
Palliative care aims to improve the quality of life for people with life-limiting illnesses. Advance care planning conversations that establish a patient's wishes and preferences for care are part of ...
The aim of this study is to explore the factors that influence the implementation of EPaCCS into routine clinical practice across different care services and settings in 2 major regions of England....
A qualitative interview study design was used, guided by Normalization Process Theory (NPT). NPT explores factors affecting the implementation of complex interventions and consists of 4 primary compon...
Participants (N=52) representing a range of professional roles were recruited across 6 care settings (hospice, primary care, care home, hospital, ambulatory, and community). In total, 6 themes were de...
EPaCCS implementation is influenced by individual, organizational, and technical factors. Key challenges include problems with access alongside inconsistent use and engagement across care settings. EP...
Despite high gender equality ratings, Sweden shows a high prevalence of intimate partner violence against women (IPVAW). Suggested factors underlying this apparent paradox include backlash effects aga...
During the pandemic, digital communication became paramount. Due to the discrepancy between the placement of the camera and the screen in typical smartphones, tablets and laptops, mutual eye contact c...
Hypertension is a major risk factor for cardiovascular disease, affecting over a billion people worldwide. Mobile health (mHealth) apps have emerged as effective tools for managing hypertension, offer...
This study aimed to explore patient-users' perspectives on the hypertension care mHealth app Hypertension.APP, focusing on its accessibility, expected benefits, potential risks, and role in hypertensi...
A qualitative study was conducted involving semistructured interviews with 20 patient-users of a hypertension care mHealth app, Hypertension.APP. Participants were recruited between January and June 2...
Participants primarily discovered the app independently, driven by recent hypertension diagnoses and insufficient information from health care professionals regarding effective self-management strateg...
Among the sample studied, mHealth apps like Hypertension.APP were valued for their continuous monitoring and educational content, aiding in hypertension management. The findings suggest potential bene...
Deutsches Register Klinischer Studien DRKS00029761; https://tinyurl.com/r33ru22s....
To explore how primary healthcare workers in Sweden experienced and perceived the long-term impact of the pandemic on their work....
This is a descriptive qualitative study with individual semistructured interviews conducted 2 years after the onset of COVID-19. Data were analysed using an inductive thematic approach....
Swedish primary healthcare units in rural and urban locations....
29 healthcare providers (6 registered nurses, 7 assistant nurses, 8 physicians and 8 managers) in Swedish primary healthcare....
Data analysis yielded three overarching themes: (1) primary healthcare still affected by the pandemic; (2) primary healthcare changes made permanent; and (3) lessons learnt for handling future crises ...
Two years after the onset of the COVID-19 pandemic, primary healthcare workers in Sweden experienced that their work was still affected by the pandemic. Our findings highlight the importance of ensuri...
The majority of junior doctors in the UK do not proceed directly into specialty training after completing mandatory foundation training but instead take a year out of training. A common post undertake...
CTFs working in Trusts in the West Midlands region registered as students on the Education for Healthcare Professionals Post Graduate Certificate course at the University of Birmingham in August 2019 ...
Nine CTFs participated in an interview. Five main themes were identified which related to their experiences in post and plans for future careers. Participants reported choosing to undertake a CTF role...
This is the first study to use interview methodology to explore experiences of CTFs, and has provided a valuable insight into the experiences of those in post in the West Midlands region. Understandin...
Encouraging alternatives to the car such as walking, cycling or public transport is a key cross-sector policy priority to promote population and planetary health. Individual travel choices are shaped ...
Prospective longitudinal qualitative cohort study utilising semi-structured interviews at baseline (in 2021), three- and six-month follow up. Participants were residents in a new town in Cambridgeshir...
We conducted 42 interviews with 16 participants and identified six mechanisms for changes in travel mode. These entailed increasing or reducing access, reliability and financial cost, improving conven...
Applying realist evaluation principles to identify common mechanisms for changes in travel mode has the potential to inform future intervention strategies. Future interventions using mechanisms that r...